Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
8.58
-0.28 (-3.16%)
Nov 20, 2024, 4:00 PM EST - Market closed
Actuate Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 168 | - | - |
| Enterprise Value | 154 | - | - |
| Quick Ratio | 1.59 | 0.43 | 4.71 |
| Current Ratio | 1.68 | 0.43 | 4.71 |
| Return on Equity (ROE) | - | -442.40% | - |
| Return on Assets (ROA) | - | -132.96% | - |
| Return on Capital (ROIC) | - | -279.06% | - |
| Buyback Yield / Dilution | -218.96% | -18.53% | - |
| Total Shareholder Return | -218.96% | -18.53% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.